Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witteman

Showing results (271-280 of 535) with videos related to

Pageof 54
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2005
Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysisMark P S Sie, Fakhredin A Sayed-Tabatabaei, Hok-Hay S Oei, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 26, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam StudyM Teichert, L E Visser, R H N van Schaik, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Application of the Rome III criteria is not likely to reduce the number of unnecessary referrals for colonoscopy in primary careLiselotte Kok, Sjoerd G Elias, Ben J M Witteman, et al.
European Journal of Epidemiology|February 7, 2013
The association between physical activity and dementia in an elderly population: the Rotterdam StudyRenée F A G de Bruijn, Elisabeth M C Schrijvers, Karen A de Groot, et al.
European Heart Journal|September 8, 2004
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam StudyGysèle S Bleumink, Anneke M Knetsch, Miriam C J M Sturkenboom, et al.
BMC Medicine|September 27, 2016
Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic studySjoerd G Elias, Liselotte Kok, Niek J de Wit, et al.
Stroke|August 28, 2010
High von Willebrand factor levels increase the risk of stroke: the Rotterdam studyRenske G Wieberdink, Marianne C van Schie, Peter J Koudstaal, et al.
Journal of Clinical Gastroenterology|June 29, 2004
Predominant symptom behavior in patients with persistent dyspepsia during treatmentRobert J F Laheij, Ruud W De Koning, Alfonds M Horrevorts, et al.
European Heart Journal|March 11, 2006
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyJan Heeringa, Deirdre A M van der Kuip, Albert Hofman, et al.
The American Journal of Cardiology|August 19, 2007
Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study)Isabella Kardys, Moniek P M de Maat, Caroline C W Klaver, et al.
Pageof 54

Showing results (271-280 of 535) with videos related to

Sort By:
Pageof 54
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2005
Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysisMark P S Sie, Fakhredin A Sayed-Tabatabaei, Hok-Hay S Oei, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 26, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam StudyM Teichert, L E Visser, R H N van Schaik, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Application of the Rome III criteria is not likely to reduce the number of unnecessary referrals for colonoscopy in primary careLiselotte Kok, Sjoerd G Elias, Ben J M Witteman, et al.
European Journal of Epidemiology|February 7, 2013
The association between physical activity and dementia in an elderly population: the Rotterdam StudyRenée F A G de Bruijn, Elisabeth M C Schrijvers, Karen A de Groot, et al.
European Heart Journal|September 8, 2004
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam StudyGysèle S Bleumink, Anneke M Knetsch, Miriam C J M Sturkenboom, et al.
BMC Medicine|September 27, 2016
Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic studySjoerd G Elias, Liselotte Kok, Niek J de Wit, et al.
Stroke|August 28, 2010
High von Willebrand factor levels increase the risk of stroke: the Rotterdam studyRenske G Wieberdink, Marianne C van Schie, Peter J Koudstaal, et al.
Journal of Clinical Gastroenterology|June 29, 2004
Predominant symptom behavior in patients with persistent dyspepsia during treatmentRobert J F Laheij, Ruud W De Koning, Alfonds M Horrevorts, et al.
European Heart Journal|March 11, 2006
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyJan Heeringa, Deirdre A M van der Kuip, Albert Hofman, et al.
The American Journal of Cardiology|August 19, 2007
Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study)Isabella Kardys, Moniek P M de Maat, Caroline C W Klaver, et al.
Pageof 54